Mankind Pharma has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI), as per a company statement.
The statement also said that the company’s Initial Public Offering (IPO) comprises an offer for sale of 40,058,884 equity shares of face value Re 1 each by selling shareholders including the promoters and the existing investors.
The offer for sale comprises up to 3,705,443 equity shares by Ramesh Juneja; up to 3,505,149 equity shares by Rajeev Juneja; up to 2,804,119 equity shares by Sheetal Arora (“Collectively, The “Promoter Selling Shareholders”); up to 17,405,559 equity shares by Cairnhill CIPEF; up to 2,623,863 equity shares by Cairnhill CGPE; up to 9,964,711 equity shares by Beige and up to 50,000 equity shares by Link Investment Trust (“Collectively, The “Investor Selling Shareholders”), the statement added.